Indian pharmaceutical company Jubilant Life Sciences has said in a statement that the company has designated Rs. 550 crores for the capital expenditure (CapEx) for...
Jubilant Life Sciences has raised Rs 100 crore through issuing commercial papers. It said in a BSE filing that the company has issued commercial papers...
The US health regulator has provided its approval to the wholly owned subsidiary of Jubilant Life Sciences for RUBY-FILL-Rubidium 82 generator and elution system that...
Jubilant Life Science has got the US health regulator’s final approval for its generic version of anti-depressant Paxil tablets. The company said in a BSE...
On Friday, Jubilant Life Science said that it has got an approval from the US health regulator to market its generic zolmitriptan orally disintegrating tablets,...